Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 133xe Radioisotope
2. Xe-133 Radioisotope
3. Xenon-133
1. Xenon-133
2. Xenon Xe 133
3. Xenon (133xe)
4. Xenon, Xe-133
5. 14932-42-4
6. Xenon (133 Xe)
7. Xenon (133xe) Gas
8. Xenon 133
9. X3p9a5hnyf
10. Xenon (133xe) [inn]
11. Xeneisol
12. Xenon Xe 133-v.s.s.
13. Xenonum (133 Xe)
14. Unii-x3p9a5hnyf
15. Xenon Xe 133 [usan]
16. Xenon, Isotope Of Mass 133
17. Mpi Xenon Xe 133 Gas Vials
18. Mpi Xenon Xe 133 Gas Ampule
19. Xe-133
20. Xenon Xe 133 [usan:usp]
21. Xenon ((sup 133)xe) Injection
22. Xenon Radioisotopes
23. Xenonum (133 Xe) [inn-latin]
24. 133xe Radioisotope
25. Xe-133 Radioisotope
26. Xenon,xe-133
27. Xenon (133xe) Injection
28. Xenon Xe 133 (tn)
29. Xenon Xe 133 Gas Vials
30. Xenon ((sup 133)xe)
31. Xenon Xe 133 Gas Ampule
32. Chembl1200685
33. Xenon Xe 133 [mi]
34. Xenon-133 [mart.]
35. Dtxsid70933614
36. Xenon,xe-133 [vandf]
37. 133xe
38. Xenon (133xe) [jan]
39. Xenon Xe 133 (jan/usp/inn)
40. Xenon (133 Xe) [who-dd]
41. Xenon Xe-133 [orange Book]
42. Db09315
43. Xenon Xe 133 [usp Monograph]
44. D06339
45. Q2451397
| Molecular Weight | 132.90591 g/mol |
|---|---|
| Molecular Formula | Xe |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 0 |
| Exact Mass | 132.90591 g/mol |
| Monoisotopic Mass | 132.90591 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 1 |
| Formal Charge | 0 |
| Complexity | 0 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Xenon xe 133 |
| Active Ingredient | Xenon xe-133 |
| Dosage Form | Gas |
| Route | Inhalation |
| Strength | 20mci/vial; 10mci/vial |
| Market Status | Prescription |
| Company | Lantheus Medcl |
| 2 of 2 | |
|---|---|
| Drug Name | Xenon xe 133 |
| Active Ingredient | Xenon xe-133 |
| Dosage Form | Gas |
| Route | Inhalation |
| Strength | 20mci/vial; 10mci/vial |
| Market Status | Prescription |
| Company | Lantheus Medcl |
Inhalation of Xenon Xe 133 Gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. It may also be applied to assessment of cerebral flow.
Xenon Xe 133 is a readily diffusible gas which is neither utilized nor produced by the body. It passes through cell membranes and freely exchanges between blood and tissue. It tends to concentrate more in body fat than in blood, plasma, water or protein solutions.
V - Various
V09 - Diagnostic radiopharmaceuticals
V09E - Respiratory system
V09EX - Other respiratory system diagnostic radiopharmaceuticals
V09EX03 - Xenon (133Xe) gas
Absorption
Inhaled Xenon Xe 133 Gas will enter the alveolar wall and enter the pulmonary venous circulation via the capillaries.
Route of Elimination
Most of the Xenon Xe 133 that enters the circulation from a single breath is returned to the lungs and exhaled after a single pass through the peripheral circulation.
Half Life 5.245 days
Xenon-133 is used for the diagnostic evaluation of pulmonary function and imaging, as well as assessment of cerebral blood flow. In the concentrations used for diagnostic purposes it is physiologically inactive.
Digital Content 
DATA COMPILATION #PharmaFlow
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
